Evidence map›Paper›PMID 35838878›Full record

ReviewCurrent osteoporosis reports2022

Functional Heterogeneity Within Osteoclast Populations-a Critical Review of Four Key Publications that May Change the Paradigm of Osteoclasts.

Neha Sharma, Megan M Weivoda, Kent Søe

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current osteoporosis reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Isolation and Generation of Osteoclasts.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  3. Article
  4. Efferocytosis and Bone Dynamics.Current osteoporosis reports · 2024
    Review
  5. Osteoclasts at Bone Remodeling: Order from Order.Results and problems in cell differentiation · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Neha SharmaClinical Cell Biology, Department of Pathology, Odense University Hospital, Odense, Denmark.
Megan M WeivodaDepartment of Hematology, Mayo Clinic, Rochester, USA.
Kent SøeClinical Cell Biology, Department of Pathology, Odense University Hospital, Odense, Denmark. Kent.soee@rsyd.dk.ORCID 0000-0001-7402-314X

Funding

Structure, Composition, & Histology Core - Core BP30AR069620 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KARL J JEPSEN · 2016 to 2026
$8.4M
The impact of age-related changes in osteoclast function on the skeleton (R01)R01AR077538 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEIVODA, MEGAN M. · 2021 to 2025
$2.1M
Role of senescence in multiple myeloma tumorigenesisU01AG075227 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEIVODA, MEGAN M. · 2021 to 2025
$2.0M
A new model for spatio-temporal coupling of bone formation and bone resorption governed by osteoclastsR61AR078073 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MISHINA, YUJI, PARK, DONGSU · 2020 to 2021
$694k
NIAMS NIH HHS P30 AR069620NIAMS NIH HHS R01 AR077538NIAMS NIH HHS R61 AR078073NIA NIH HHS U01 AG075227
6 · The paper itself

Abstract

purpose of reviewIn this review, we critically evaluate the literature for osteoclast heterogeneity, including heterogeneity in osteoclast behavior, which has hitherto been unstudied and has only recently come to attention. We give a critical review centered on four recent high-impact papers on this topic and aim to shed light on the elusive biology of osteoclasts and focus on the variant features of osteoclasts that diverge from the classical viewpoint. RECENT

findingsOsteoclasts originate from the myeloid lineage and are best known for their unique ability to resorb bone. For decades, osteoclasts have been defined simply as multinucleated cells positive for tartrate-resistant acid phosphatase activity and quantified relative to the bone perimeter or surface in histomorphometric analyses. However, several recent, high-profile studies have demonstrated the existence of heterogeneous osteoclast populations, with variable origins and functions depending on the microenvironment. This includes long-term persisting osteoclasts, inflammatory osteoclasts, recycling osteoclasts (osteomorphs), and bone resorption modes. Most of these findings have been revealed through murine studies and have helped identify new targets for human studies. These studies have also uncovered distinct sets of behavioral patterns in heterogeneous osteoclast cultures. The underlying osteoclast heterogeneity likely drives differences in bone remodeling, altering patient risk for osteoporosis and fracture. Thus, identifying the underlying key features of osteoclast heterogeneity may help in better targeting bone diseases.

Indexed as

Bone ResorptionOsteoclastsAnimalsBone and BonesBone RemodelingCell DifferentiationHumansMiceTartrate-Resistant Acid PhosphataseTartrate-Resistant Acid PhosphataseBone resorptionErythromyeloidInflammatory osteoclastsLongevityOsteoclastOsteomorphs

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.